Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Current therapy of multiple sclerosis].
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis.
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Hyaluronan Anchored to Activated CD44 on CNS Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis.
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Longitudinally extensive varicella-zoster virus myelitis in a multiple sclerosis patient.
Blood Plasma Levels of Microelements in Patients with History of Optic Neuritis.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Neurobehavioral and cytotoxic effects of vanadium during oligodendrocyte maturation: A protective role for erythropoietin.
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review.
Dendritic Cells and Anergic Type I NKT Cells Play a Crucial Role in Sulfatide-Mediated Immune Regulation in Experimental Autoimmune Encephalomyelitis.
Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE).
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
[Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? No].
Myeloid cell-based therapies in neurological disorders: How far have we come?
Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis.
Diffuse Granulomatous Inflammation Associated With Long-term Interferon-β Therapy.
Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands.
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
The Use of Fourth-generation Optical Coherence Tomography in Multiple Sclerosis: A Review.
Amyotrophic lateral sclerosis and multiple sclerosis overlap: a case report.
Pages
« first
‹ previous
…
441
442
443
444
445
446
447
448
449
…
next ›
last »